Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qvella has developed the Field Activated Sample Treatment (FAST) system—a fully automated diagnostic platform that enables rapid isolation, concentration, lysis, amplification, and detection of pathogens directly from whole blood. This allows clinicians to obtain actionable microbiology results within minutes rather than hours or days. The system has received CE marking for use in Europe and has been validated at several healthcare centers. It aims to improve patient outcomes by enabling faster diagnosis and treatment decisions for bloodstream infections such as sepsis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qvella.